Litcius/Paper detail

Arylacetamide deacetylase as a determinant of the hydrolysis and activation of abiraterone acetate in mice and humans

Yoshiyuki Sakai, Tatsuki Fukami, Mai Nagaoka, Keiya Hirosawa, Hiroyuki Ichida, Rei Sato, Kohei Suzuki, Masataka Nakano, Miki Nakajima

2021Life Sciences21 citationsDOI

Topics & Concepts

Abiraterone acetateChemistryHydrolysisPharmacologyBiochemistryMedicineInternal medicineCancerProstate cancerAndrogen deprivation therapyHistone Deacetylase Inhibitors ResearchProstate Cancer Treatment and ResearchCancer, Lipids, and Metabolism
Arylacetamide deacetylase as a determinant of the hydrolysis and activation of abiraterone acetate in mice and humans | Litcius